Renalytix Plc
Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for clinical management of kidney diseases in Europe and the United States. It offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics, and personalized patient data from … Read more
Renalytix Plc (RNLXY) - Total Assets
Latest total assets as of December 2024: $11.44 Million USD
Based on the latest financial reports, Renalytix Plc (RNLXY) holds total assets worth $11.44 Million USD as of December 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Renalytix Plc - Total Assets Trend (2021–2025)
This chart illustrates how Renalytix Plc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Renalytix Plc - Asset Composition Analysis
Current Asset Composition (June 2025)
Renalytix Plc's total assets of $11.44 Million consist of 95.1% current assets and 4.9% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 59.0% |
| Accounts Receivable | $600.00K | 9.8% |
| Inventory | $200.00K | 3.3% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2021–2025)
This chart illustrates how Renalytix Plc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Renalytix Plc's current assets represent 95.1% of total assets in 2025, an increase from 74.1% in 2021.
- Cash Position: Cash and equivalents constituted 59.0% of total assets in 2025, down from 63.5% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 17.0% in 2021.
- Asset Diversification: The largest asset category is accounts receivable at 9.8% of total assets.
Renalytix Plc Competitors by Total Assets
Key competitors of Renalytix Plc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
| No similar companies found. | ||
Renalytix Plc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Renalytix Plc generates 0.49x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Renalytix Plc is currently not profitable relative to its asset base.
Renalytix Plc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.43 | 0.68 | 1.09 |
| Quick Ratio | 2.34 | 0.64 | 1.09 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $6.58 Million | $ -4.43 Million | $ 1.30 Million |
Renalytix Plc - Advanced Valuation Insights
This section examines the relationship between Renalytix Plc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 18.39 |
| Latest Market Cap to Assets Ratio | 13.35 |
| Asset Growth Rate (YoY) | -23.5% |
| Total Assets | $6.10 Million |
| Market Capitalization | $81.41 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Renalytix Plc's assets at a significant premium ( 13.35x), suggesting investors see substantial growth potential or unique competitive advantages.
Significant Asset Reduction: Renalytix Plc's assets decreased by 23.5% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Renalytix Plc (2021–2025)
The table below shows the annual total assets of Renalytix Plc from 2021 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-06-30 | $6.10 Million | -23.48% |
| 2024-06-30 | $7.97 Million | -73.97% |
| 2023-06-30 | $30.63 Million | -38.82% |
| 2022-06-30 | $50.06 Million | -51.19% |
| 2021-06-30 | $102.58 Million | -- |